Joint health, because promising results have been seen in osteoarthritis and osteoporosis
Despite these challenges, the potential of BPC 157 as a therapeutic agent remains significant
Most experts recommend: Limiting use to 46 week cycles Taking 48 week breaks between cycles Avoiding chronic daily use unless supervised by a clinician BPC-157s long-term effects remain uncharacterized in humans, and chronic angiogenesis stimulation raises theoretical concerns. Perovic, D
In about 17,600 adults with obesity and established cardiovascular disease but no diabetes, semaglutide cut major cardiovascular events by 20% over roughly 40 months. This is a secondary-prevention result in people who already had heart disease
CVZ, (pharmaceutical reference book) Amstelveen 2011 4
BPC-157 was found to speed up functional recovery following Achilles tendon detachment in rat models, resulting in faster tendon-to-bone healing